Expert NetworkExpert InterviewTGTX

Slingshot members are talking to an expert! The topic is:

A Second View: Discussing the potential of CD20 as class in treating Multiple Sclerosis with a focus on BRIUMVI, Kesimpta, and Ocrevus

Executed on:May 12, 2023 5:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: UPenn
  • Director Emeritus, Multiple Sclerosis Center and Associate Professor of Neurology at the University of Pennsylvania.
  • Treats 1500 patients with Multiple Sclerosis.
  • Clinical expertise include Multiple Sclerosis (MS), Parkinsons, Myasthenia Gravis and other neuromuscular diseases; Research interest focuses on the development of new compounds for the treatment of multiple sclerosis (MS) and the utilization of new MRI techniques to study MS pathogenesis and immunology.

Interview Goal

This conversation will focus on the multiple sclerosis treatment landscape. We will dig into CD20 agents and get an expert's view on how this class performs in treatment.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.